NCT00572806View on ClinicalTrials.gov

Initiation of Insulin Aspart in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

February 5, 2003

Primary Completion Date

February 2, 2004

Study Completion Date

February 2, 2004

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin aspart

Trial Locations (1)

34295

Novo Nordisk Investigational Site, Montpellier

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY